Signet Financial Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Signet Financial Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-7,256	Closed	-$508K	–	201
2015 Q4	$508K	Sell	7,256 -14,370	-66%	-$1.02M	0.1%	110
2015 Q3	$1.44M	Buy	21,626 +4,383	+25%	+$341K	0.32%	65
2015 Q2	$1.35M	Buy	17,243 +13,023	+309%	+$1.01M	0.31%	71
2015 Q1	$322K	Buy	+4,220	New	+$310K	0.09%	133

Other funds holding PJP

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

SCM

Summit Capital Management Seattle, Washington $221M AUM 4.14% 1-Year Est. Return

Signet Financial Management's PJP Position: Q1 2016 in Review

Signet Financial Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2016, closing a stake of 7,256 shares — an estimated $508K sold.

Signet Financial Management first reported a position in PJP in Q1 2015 and held it in 4 quarters. The position peaked at $1.44M in Q3 2015. 93 funds tracked by Wall St. Rank hold PJP as of Q1 2016.

Signet Financial Management reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2016 after selling out during the quarter.
Signet Financial Management sold 7,256 Invesco Pharmaceuticals ETF shares in Q1 2016, an estimated $508K.
Signet Financial Management first reported a position in Invesco Pharmaceuticals ETF in Q1 2015 and held it in 4 quarters.
Signet Financial Management's Invesco Pharmaceuticals ETF position peaked at $1.44M in Q3 2015.
93 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2016.

Based on Signet Financial Management's 13F filing for Q1 2016, filed 16 May 2016.